Skip to main content

Rubicon Organics Inc(ROMJ-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.570
Day High0.570
Open:0.570
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Rubicon Organics Launches 1964 Supply Co.™ in the U.K.
GlobeNewswire
Rubicon Organics to Present at International Cannabis Conferences in April 2026
GlobeNewswire
Rubicon Organics Reports 2025 Financial Results
GlobeNewswire
Rubicon Organics to Report Q4 2025 Results
GlobeNewswire
Rubicon Organics Marks Cascadia Facility Grand Opening with Completion of First Harvest
GlobeNewswire
Rubicon Organics Announces Grant of RSUs and PSUs
GlobeNewswire
Rubicon Organics Announces Closing of its Previously Announced Credit Agreements with Community Savings Credit Union
GlobeNewswire
Rubicon Organics Celebrates Multiple Wins at KIND Awards 2025
GlobeNewswire
Rubicon Organics Reports Q3 2025 Financial and Operating Results
GlobeNewswire
Rubicon Organics Announces Appointment of Glen Ibbott as CFO
GlobeNewswire
Rubicon Organics Secures $4 million in Financing to Support Strategic Growth Initiatives
GlobeNewswire
Rubicon Organics to Report Q3 2025 Results
GlobeNewswire
Rubicon Organics Announces Fifth Annual Environmental, Social, & Governance Report
GlobeNewswire
Rubicon Organics Announces Health Canada Cultivation License For Cascadia (Hope, BC) Facility
GlobeNewswire
Rubicon Organics to Present at Small Cap Discoveries in Vancouver and Planet MicroCap Showcase in Toronto
The Globe and Mail
Insiders point to opportunity in Canadian cannabis
Cannabis plants grow inside of Thrive Cannabis' production facility in Simcoe, Ont. Tuesday, April 13, 2021. A group convened by the federal government to study the act that legalized cannabis is recommending the country review the excise taxes it charges pot companies. THE CANADIAN PRESS/Tara Walton
GlobeNewswire
Rubicon Organics Reports Q2 2025 Financial and Operating Results
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics Launches 1964 Supply Co.™ All-in-One FSE Resin Vapes in Canada
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics Clears Conditions for Hope Facility Acquisition, Advancing Growth Strategy
GlobeNewswire
Rubicon Organics to Report Q1 2025 Results
INK Research
Off-market insider buying at Rubicon Organics (ROMJ)
Company Chart of ROMJ
GlobeNewswire
Rubicon Organics Announces Closing of Private Placement Offering under the Listed Issuer Financing Exemption
GlobeNewswire
Rubicon Organics Announces Upsize of Private Placement Offering under the Listed Issuer Financing Exemption
GlobeNewswire
Rubicon Organics Announces Proposed Private Placement Offering under the Listed Issuer Financing Exemption
GlobeNewswire
Rubicon Organics to Present at The Planet MicroCap Showcase in Las Vegas, NV and at ICBC Berlin B2B in Berlin, Germany
GlobeNewswire
Rubicon Organics Reports 2024 Financial Results
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics to Report Q4 2024 Results
GlobeNewswire
Rubicon Organics Marks Milestone with First-Ever International Shipment
Newswire.ca
MediPharm Labs to Sell its Hope Facility to Rubicon Organics for $4.5M

Profile

Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.